The Role of FDA CDER Statisticians in Response Efforts to the COVID-19 Pandemic-Reference-Cited by-同舟云学术

The Role of FDA CDER Statisticians in Response Efforts to the COVID-19 Pandemic

Published:2020-12-23 Issue:1 Volume:14 Page:3-4
ISSN:1946-6315
Container-title:Statistics in Biopharmaceutical Research
language:en
Short-container-title:Statistics in Biopharmaceutical Research

Author:

Collins Sylva H.¹,Price Dionne²,Johnson Laura Lee³

Affiliation:

1. Office of Biostatistics, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD;

2. Division of Biometrics IV, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD;

3. Division of Biometrics III, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,Statistics and Probability

Link

https://www.tandfonline.com/doi/pdf/10.1080/19466315.2020.1841024

Reference13 articles.

1. ClinicalTrials.gov (2020a), Bethesda (MD): National Library of Medicine (US). Available at https://clinicaltrials.gov/show/NCT04280705

2. ClinicalTrials.gov (2020b), Bethesda (MD): National Library of Medicine (US). Available at https://clinicaltrials.gov/show/NCT04401579

3. ClinicalTrials.gov (2020c), Bethesda (MD): National Library of Medicine (US). Available at https://clinicaltrials.gov/show/NCT04492475

4. C-TAP Dashboard (2020), Available at https://www.fda.gov/drugs/coronavirus-covid-19-drugs/coronavirus-treatment-acceleration-program-ctap

5. Department of Health and Human Services. (2020), “Determination that a Public Health Emergency Exists.” Available at https://www.phe.gov/emergency/news/healthactions/phe/Pages/2019-nCoV.aspx.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Statistical Issues and Challenges in Clinical Trials for COVID-19 Treatments, Vaccines, Medical Devices and Diagnostics;Statistics in Biopharmaceutical Research;2021-12-13